Added to YB: 2016-04-11
Pitch date: 2016-04-11
ITCI:US [bullish]
Intra-Cellular Therapies, Inc.
+801.37%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Intra-Cellular Therapies, Inc. operates as a biopharmaceutical company that develops and commercializes therapeutics and small molecule drugs for central nervous system (CNS), neuropsychiatric, and neurological disorders.
Market Cap
$14.0B
Pitch Price
$14.63
Price Target
N/A
Dividend
N/A
EV/EBITDA
-120.75
P/E
-182.12
EV/Sales
19.15
Sector
Pharmaceuticals
Category
N/A
Show full summary:
Intra-Cellular Therapies, Inc. ITCI:US
A summary for this pitch has not been created yet.
Read full article (0 min)